Fujian Haixi Pharmaceuticals Co., Ltd. Class HHKEX: 2637

Fujian Haixi Pharmaceuticals Says US FDA Approves IND Application Of HX9428

· Issued by Fujian Haixi Pharmaceuticals Co., Ltd. Class H

Fujian Haixi Pharmaceuticals Co Ltd HKEX:2637:

  • U.S. FDA APPROVES IND APPLICATION OF HX9428 FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

Earlier from Fujian Haixi Pharmaceuticals Co., Ltd. Class H

All Fujian Haixi Pharmaceuticals Co., Ltd. Class H news releases